Frequent PD-L1 expression in testicular germ cell tumors

por Fankhauser, C D, Curioni-Fontecedro, A, Allmann, V, Beyer, J, Tischler, V, Sulser, T, Moch, H, Bode, P K
Publicado 2015

Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma

por Curioni-Fontecedro, A., Pitocco, R., Schoenewolf, N. L., Holzmann, D., Soldini, D., Dummer, R., Calvieri, S., Moch, H., Mihic-Probst, D., Fitsche, A.
Publicado 2015

Erratum to “Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma”

por Curioni-Fontecedro, A., Pitocco, R., Schoenewolf, N. L., Holzmann, D., Soldini, D., Dummer, R., Calvieri, S., Moch, H., Fitsche, A., Mihic-Probst, D.
Publicado 2019

The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung Cancer

por Akhoundova, D., Mosquera Martinez, J., Musmann, L. E., Britschgi, C., Rütsche, C., Rechsteiner, M., Nadal, E., Garcia Campelo, M. R., Curioni-Fontecedro, A.
Publicado 2020

Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials

por König, D., Schär, S., Vuong, D., Guckenberger, M., Furrer, K., Opitz, I., Weder, W., Rothschild, S.I., Ochsenbein, A., Zippelius, A., Addeo, A., Mark, M., Eboulet, E.I., Hayoz, S., Thierstein, S., Betticher, D.C., Ris, H.-B., Stupp, R., Curioni-Fontecedro, A., Peters, S., Pless, M., Früh, M.
Publicado 2022

Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/0...

por König, D., Savic Prince, S., Hayoz, S., Zens, P., Berezowska, S., Jochum, W., Stauffer, E., Braunersreuther, V., Trachsel, B., Thierstein, S., Mark, M., Schmid, S., Curioni-Fontecedro, A., Addeo, A., Opitz, I., Guckenberger, M., Früh, M., Betticher, D.C., Ris, H.-B., Stupp, R., Rothschild, S.I., Bubendorf, L., Pless, M.
Publicado 2023

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

por Mazieres, J., Drilon, A., Lusque, A., Mhanna, L., Cortot, A.B., Mezquita, L., Thai, A.A., Mascaux, C., Couraud, S., Veillon, R., Van den Heuvel, M., Neal, J., Peled, N., Früh, M., Ng, T.L., Gounant, V., Popat, S., Diebold, J., Sabari, J., Zhu, V.W., Rothschild, S.I., Bironzo, P., Martinez-Marti, A., Curioni-Fontecedro, A., Rosell, R., Lattuca-Truc, M., Wiesweg, M., Besse, B., Solomon, B., Barlesi, F., Schouten, R.D., Wakelee, H., Camidge, D.R., Zalcman, G., Novello, S., Ou, S.I., Milia, J., Gautschi, O.
Publicado 2019